| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.09 |